Immediate exposure to TNF-α activates dendritic cells derived from non-purified cord blood mononuclear cells

Iranian Journal of Immunology

Volumn 6, Issue 3, 2009, Pages 107-118

  Ebrahimi, Marzieh ^a,c   Hassan, Zuhair Mohammad ^a   Hadjati, Jamshid ^b   Hayat, Parisa ^d   Moazzeni, Seyed Mohammad ^a  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^d IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cord Blood; Dendritic Cells; TNF

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; FLT3 LIGAND PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IL10 PROTEIN, HUMAN; IL4 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 4; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CELL MATURATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PHENOTYPE; T LYMPHOCYTE; TH1 CELL; UMBILICAL CORD BLOOD; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECT; FETUS BLOOD; IMMUNOLOGY; METABOLISM;

ADJUVANTS, IMMUNOLOGIC; ANTIGENS, CD; DENDRITIC CELLS; FETAL BLOOD; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; MEMBRANE PROTEINS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74049109774     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Steinman RM, Inaba K. Myeloid dendritic cells. J Leukoc Biol. 1999; 66: 205-8.
2. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S. Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol. 2002; 20: 621-67.
3. Szabolcs P, Avigan D, Gezelter S, Ciocon DH, Moore MA., Steinman RM, et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood. 1996; 87: 4520-30.
4. Caux C, Vanbervliet B, Massacrier C, Dezutter-Dambuyant C, de Saint-Vis B, Jacquet C, et al. CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha. J Exp Med. 1996; 184: 695-706.
5. Morrison RS 3rd, Cruse JM, Wang H, Lewis RE. Dendritic cell differentiation and proliferation: enhancement by tumor necrosis factor-alpha. Exp Mol Pathol. 2003; 75: 228-37.
6. Santiago-Schwarz F, Divaris N, Kay C, Carsons SE. Mechanisms of tumor necrosis factor-granulocyte-macrophage colonystimulating factor-induced dendritic cell development. Blood. 1993; 82: 3019-28.
7. Bender A, Sapp M, Schuler G, Steinman RM, Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods. 1996; 196: 121-135.
8. Thurner B, Röder C, Dieckmann D, Heuer M, Kruse M, Glaser A, et al. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application. J Immunol Methods. 1999; 223:1-15.
9. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature; 1992: 360:258-61.
10. Dietz AB, Bulur PA, Erickson MR, Wettstein PJ, Litzow MR, Wyatt WA, et al. Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells. J Hematother Stem Cell Res. 2000; 9:95-101.
11. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med. 1994; 179:1109-18.
12. Dilioglou S, Cruse JM, Lewis RE. Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp Mol Pathol. 2003; 75: 217-27.
13. Hong L, Webb TJ, Wilkes DS. Dendritic cell-T cell interactions: CD8 alpha alpha expressed on dendritic cells regulates T cell proliferation. Immunol Lett. 2007; 108: 174-8.
14. Varas A, Jimenez E, Sacedon R, Rodriguez-Mahou M, Maroto E, Zapata A, et al. Analysis of the human neonatal thymus: evidence for a transient thymic involution. J Immunol. 2000; 164: 6260-7.
15. Santiago-Schwarz F, Belilos E, Diamond B, Carsons SE. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages. J Leukoc Biol. 1992; 52: 274-81.
16. Reid CD, Stackpoole A., Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colonystimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol. 1992; 149: 2681-8.
17. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science. 1999; 283: 1183-6.
18. Caux C, Durand I, Moreau I, Duvert V, Saeland S, Banchereau J. Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors. J Exp Med. 1993; 177:1815-20.
19. Jacobsen SE, Ruscetti FW, Dubois CM, Keller JR. Tumor necrosis factor alpha directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation. J Exp Med. 1992;175:1759-72.
20. Caux C. Pathways of development of human dendritic cells. Eur J Dermatol. 1998; 8: 375-84.
21. Szabolcs P, Feller ED, Moore MA., Young JW. Progenitor recruitment and in vitro expansion of immunostimulatory dendritic cells from human CD34+ bone marrow cells by c-kit-ligand, GM-CSF, and TNF alpha. Adv Exp Med Biol. 1995; 378: 17-20.
22. Lardon F, Snoeck HW, Berneman ZN, Van Tendeloo VF, Nijs G, Lenjou M, et al. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1. Immunology. 1997; 91: 553-9.
23. Curti A., Isidori A, Ferri E, Terragna C, Neyroz P, Cellini C, et al. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. Leuk Lymphoma. 2004; 45:1419-28.
24. Santiago-Schwarz F, McCarthy M, Tucci J, Carsons SE. Neutralization of tumor necrosis factor activity shortly after the onset of dendritic cell hematopoiesis reveals a novel mechanism for the selective expansion of the CD14-dependent dendritic cell pathway. Blood. 1998; 92:745-55.
25. Noirey N, Staquet MJ, Gariazzo MJ, Serres M, Dezutter-Dambuyant C, André C, et al. Withdrawal of TNF-alpha after the fifth day of differentiation of CD34+ cord blood progenitors generates a homogeneous population of Langerhans cells and delays their maturation. Exp Dermatol. 2003; 12:96-105.
26. Reid CD, Stackpoole A, Meager A, Tikerpae J. Interactions of tumor necrosis factor with granulocyte-macrophage colonystimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow. J Immunol. 1992; 149:2681-8.
27. Moore FD Jr, Socher SH, Davis C. Tumor necrosis factor and endotoxin can cause neutrophil activation through separate pathways. Arch Surg. 1991; 126:70-3.
28. Bryder D, Ramsfjell V, Dybedal I, Theilgaard-Mönch K, Högerkorp CM, Adolfsson J, et al. Self-renewal of multipotent longterm repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation. J Exp Med. 2001; 194:941-52.
29. Dybedal I, Bryder D, Fossum A, Rusten LS, Jacobsen SE. Tumor necrosis factor (TNF)-mediated activation of the p55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells. Blood. 2001; 98:1782-91.
30. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci U S A. 1996; 93: 2588-92.
31. Morse MA., Vredenburgh JJ, Lyerly HK. A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy. J Hematother Stem Cell Res. 1999; 8: 577-84.
32. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998; 392: 245-52.
33. Bender A., Sapp M, Feldman M, Reddy A, Seder R, Schuler G, et al. Dendritic cells as immunogens for human CTL responses. Adv Exp Med Biol. 1997; 417: 383-7.
34. Xu RL, Tang Y, Ogburn PL, Malinowski K, Madajewicz S, Santiago-Schwarz F, et al. Implication of delayed TNF-alpha exposure on dendritic cell maturation and expansion from cryopreserved cord blood CD34+ hematopoietic progenitors. J Immunol Methods. 2004; 293:169-82.